Guardian Pharmacy Services, Inc. reports results for the quarter ended June 30 - Earnings Summary

Guardian Pharmacy Services

07/08/2026 24:40

Guardian Pharmacy Services, Inc. GRDN.N reported quarterly adjusted earnings of 34 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 14 cents.  The mean expectation of six analysts for the quarter was for earnings of 27 cents per share. Wall Street expected results to range from 25 cents to 29 cents per share.
Revenue rose 2.2% to $351.77 million from a year ago; analysts expected $340.04 million. 
Guardian Pharmacy Services, Inc.'s reported EPS for the quarter was 34 cents​.
The company reported quarterly net income of $21.87 million.
Guardian Pharmacy Services, Inc. shares had fallen by 3.3% this quarter and gained 34.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 6.1% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the drug retailers peer group is  "buy."
Wall Street's median 12-month price target for Guardian Pharmacy Services, Inc. is $48.00, about 17.8% above its last closing price of $39.47
This summary was machine generated from LSEG data August 6 at 11:40 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.27
0.34
Beat
Mar. 31 2026 
0.23
0.21
Missed
Dec. 31 2025 
0.25
0.33
Beat
Sep. 30 2025 
0.17
0.15
Missed